These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20081589)

  • 1. Monitoring and management of heparin-induced thrombocytopenia.
    Rogers B; Little Nj; Jones C
    Br J Hosp Med (Lond); 2009 Nov; 70(11):630-3. PubMed ID: 20081589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-induced thrombocytopenia in surgical patients.
    Battistelli S; Genovese A; Gori T
    Am J Surg; 2010 Jan; 199(1):43-51. PubMed ID: 20103065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparins, low-molecular-weight heparins, and pentasaccharides.
    Dinwoodey DL; Ansell JE
    Clin Geriatr Med; 2006 Feb; 22(1):1-15, vii. PubMed ID: 16377464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of heparin induced thrombocytopenia treated with lepirudin infusion: case report].
    Sünmez S; Okumuş G; Kiyan E; Ece T; Arseven O
    Tuberk Toraks; 2006; 54(2):185-8. PubMed ID: 16924578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A benchmark for platelet count monitoring with low-molecular-weight heparin: expanding implementation of National Patient Safety Goals.
    Spinler SA
    Ann Pharmacother; 2009 Sep; 43(9):1519-21. PubMed ID: 19690223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unfractionated heparin versus low-molecular-weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients.
    Ang E
    Clin Nurse Spec; 2013; 27(5):229-30. PubMed ID: 23942101
    [No Abstract]   [Full Text] [Related]  

  • 7. [Heparin-induced thrombocytopenia after elective hip joint replacement with postoperative prevention of thromboembolism with low-molecular-weight heparin].
    Marx A; Huhle G; Hoffmann U; Wang LC; Schüle B; Jani L; Harenberg J
    Z Orthop Ihre Grenzgeb; 1999; 137(6):536-9. PubMed ID: 10666863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. So, does low-molecular-weight heparin cause less heparin-induced thrombocytopenia than unfractionated heparin or not?
    Warkentin TE; Greinacher A
    Chest; 2007 Oct; 132(4):1108-10. PubMed ID: 17934108
    [No Abstract]   [Full Text] [Related]  

  • 9. An unusual presentation of heparin-induced thrombocytopenia in the setting of catheter-directed ablation of atrial fibrillation.
    Vaidya R; Pruthi R; Thompson C
    Blood Coagul Fibrinolysis; 2014 Mar; 25(2):188-90. PubMed ID: 24300023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low molecular weight heparins--a safer option than unfractionated heparin?
    McKay GA; Paterson KR
    Adverse Drug React Toxicol Rev; 2001 Dec; 20(4):256-76. PubMed ID: 11770172
    [No Abstract]   [Full Text] [Related]  

  • 11. [State of the art: low-molecular-weight heparin and beyond].
    Cimminiello C; Casali G; Vitali L
    Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):61-5. PubMed ID: 11253343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and diagnosis of heparin-induced thrombocytopenia (HIT) in patients with traumatic injuries treated with unfractioned or low-molecular-weight heparin: a literature review.
    Bloemen A; Testroote MJ; Janssen-Heijnen ML; Janzing HM
    Injury; 2012 May; 43(5):548-52. PubMed ID: 21640991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology, epidemiology, diagnosis and treatment of heparin-induced thrombocytopenia (HIT).
    Picker SM; Gathof BS
    Eur J Med Res; 2004 Apr; 9(4):180-5. PubMed ID: 15210398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Heparin therapy in pregnant women].
    Schleich JM; Laurent M; Almange C
    Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1291-300. PubMed ID: 11794972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of low-molecular-weight heparins in pregnancy--how safe are they?
    Deruelle P; Coulon C
    Curr Opin Obstet Gynecol; 2007 Dec; 19(6):573-7. PubMed ID: 18007136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of heparin-induced thrombocytopenia with fondaparinux.
    Harenberg J; Jörg I; Fenyvesi T
    Haematologica; 2004 Aug; 89(8):1017-8. PubMed ID: 15339691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.
    Breddin HK; Hach-Wunderle V; Nakov R; Kakkar VV;
    N Engl J Med; 2001 Mar; 344(9):626-31. PubMed ID: 11228276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin, low molecular weight heparin, and heparin-induced thrombocytopenia in the ICU.
    Warkentin TE; Cook DJ
    Crit Care Clin; 2005 Jul; 21(3):513-29. PubMed ID: 15992671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evidence-based guidelines for prevention and therapy of venous thromboembolism].
    Falciani M; Dilaghi B; Conti AA; Caciolli S; Gensini GF
    Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):27-35. PubMed ID: 11253337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why low molecular weight heparin?
    Mammen EF
    Semin Thromb Hemost; 1990 Oct; 16 Suppl():1-4. PubMed ID: 1962897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.